Technical Analysis for BNR - Burning Rock Biotech Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.36% | |
Narrow Range Bar | Range Contraction | -0.36% | |
Wide Bands | Range Expansion | -0.36% | |
Gapped Down | Weakness | -0.36% | |
Oversold Stochastic | Weakness | -0.36% | |
Bullish Engulfing | Bullish | -1.06% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 22 hours ago |
Down 5% | about 22 hours ago |
Down 3% | about 22 hours ago |
Non-ADX 1,2,3,4 Bearish Retracement Entry | about 22 hours ago |
Fell Below Previous Day's Low | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/29/2024
Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.5 |
52 Week Low | 2.62 |
Average Volume | 34,569 |
200-Day Moving Average | 6.58 |
50-Day Moving Average | 3.71 |
20-Day Moving Average | 3.03 |
10-Day Moving Average | 2.85 |
Average True Range | 0.33 |
RSI (14) | 34.21 |
ADX | 13.27 |
+DI | 20.36 |
-DI | 20.18 |
Chandelier Exit (Long, 3 ATRs) | 4.66 |
Chandelier Exit (Short, 3 ATRs) | 3.64 |
Upper Bollinger Bands | 3.58 |
Lower Bollinger Band | 2.49 |
Percent B (%b) | 0.29 |
BandWidth | 35.78 |
MACD Line | -0.27 |
MACD Signal Line | -0.31 |
MACD Histogram | 0.0397 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.03 | ||||
Resistance 3 (R3) | 3.00 | 2.90 | 2.99 | ||
Resistance 2 (R2) | 2.90 | 2.84 | 2.91 | 2.98 | |
Resistance 1 (R1) | 2.85 | 2.81 | 2.88 | 2.88 | 2.96 |
Pivot Point | 2.75 | 2.75 | 2.76 | 2.76 | 2.75 |
Support 1 (S1) | 2.70 | 2.69 | 2.72 | 2.72 | 2.64 |
Support 2 (S2) | 2.60 | 2.66 | 2.61 | 2.62 | |
Support 3 (S3) | 2.55 | 2.60 | 2.61 | ||
Support 4 (S4) | 2.57 |